GAD2 and type 1 diabetes mellitus: Other upregulated transcripts included GAD2, i.e. T1D autoantibody target GAD65 (32), IGF2, whose enrichment induces β cell dysfunction (33), and amyloid markers IAPP and APP, both implicated in T1D (34) and influencing islet behavior (35).